This is the authors' abstract. We don't add key points for this paper.
A series of 4-substituted phenoxypropanolamines was prepared and examined for beta-adrenoceptor activity. Some of the compounds, especially the [4-[2-[[2-(4-fluorophenyl)ethyl] oxy]ethoxy]phenoxy]propanolamines (14, 15, and 24), showed potent beta 1-blockade with virtually no beta 2-blockade at doses over a 1000 times greater. The compounds also possessed partial agonist activity. Structure-activity relationships are discussed, and conclusions are drawn about the binding sites on beta-adrenoceptors.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Machin et al. (1983) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: